3Q5-28638-09566
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 372 / TN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Pyrexia, Rhinorrhoea — Feeling: Fair · Fever · Chills, Fatigue or tiredness, NauseaFree text: Felt feverish without fever, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-24
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-26
- 2021-01-28
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-26
- 2021-03-03
- 2021-04-21
- 2021-07-22
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: SyncopeMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-29
-
2022-09-28
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Contracted COVID 19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Felt feverish without fever, runny nose
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Syncope
Release 12 — 12 months, dose 3
Symptoms: Contracted COVID 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Syncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release